1. Home
  2. INAB vs SOAR Comparison

INAB vs SOAR Comparison

Compare INAB & SOAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.10

Market Cap

11.8M

Sector

Health Care

ML Signal

HOLD

Logo Volato Group Inc.

SOAR

Volato Group Inc.

HOLD

Current Price

$0.19

Market Cap

11.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
INAB
SOAR
Founded
2016
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
11.3M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
INAB
SOAR
Price
$1.10
$0.19
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
59.6K
35.4M
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
104.83
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$0.10
52 Week High
$2.73
$4.36

Technical Indicators

Market Signals
Indicator
INAB
SOAR
Relative Strength Index (RSI) 46.57 52.11
Support Level $0.92 $0.19
Resistance Level $1.50 $0.20
Average True Range (ATR) 0.08 0.04
MACD 0.00 -0.00
Stochastic Oscillator 39.71 28.97

Price Performance

Historical Comparison
INAB
SOAR

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

About SOAR Volato Group Inc.

Volato Group Inc is an aviation technology company that connects travelers to private, on-demand flight access and develops proprietary software platforms for enterprise and operational applications. The company operates in a single operating and reportable segment, private aviation services. It operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.

Share on Social Networks: